Prevalence of SARS-CoV-2-Specific Antibodies, Japan, June 2020.

Category Primary study
JournalEmerging infectious diseases
Year 2021
We used 2 commercially available antibody tests to estimate seroprevalence of severe acute respiratory syndrome coronavirus 2 infection in Japan during June 2020. Of 7,950 samples, 8 were positive by both assays. Using 2 reliable antibody tests in conjunction is an effective method for estimating seroprevalence in low prevalence settings.
Epistemonikos ID: 245a4ee90d130d375a9142baff1e46f366818df7
First added on: Jan 27, 2021